LUX Infusion Bleeding Disorders

10/10/2026

𝗟𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗮 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝗰𝗮𝗻 𝗰𝗮𝗿𝗿𝘆 𝗮𝗻 𝗲𝗺𝗼𝘁𝗶𝗼𝗻𝗮𝗹 𝘄𝗲𝗶𝗴𝗵𝘁 𝘁𝗵𝗮𝘁 𝗼𝘁𝗵𝗲𝗿𝘀 𝗺𝗮𝘆 𝗻𝗼𝘁 𝗮𝗹𝘄𝗮𝘆𝘀 𝘀𝗲𝗲.

Worrying about bleeds, pain, treatment, insurance, or simply feeling different can become overwhelming over time.

In recognition of World Mental Health Day, our latest article explores signs that it may be time to reach out, ways to find support, and small steps that can help patients and caregivers care for their emotional well-being.

Because mental health is part of your overall care—and asking for help is a form of strength.

Read more: https://hubs.la/Q04z8RM20

If you or someone you know is experiencing a mental health crisis, call or text 988. If there is immediate danger, call 911.

World Mental Health Day: Caring for Your Mental Health with a Bleeding Disorder

10/09/2026

𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗛𝗲𝗺𝗼𝗽𝗵𝗶𝗹𝗶𝗮 𝗖𝗮𝗿𝗲

LUX Infusion is now authorized to dispense Qfitlia® (fitusiran), broadening treatment options for people living with hemophilia A or B.

Our support goes beyond access—from navigating benefits and appeals to coordinating with Hemophilia Treatment Centers, we help patients move through their treatment journey with a dedicated point of contact and 24/7 on-call guidance.

Read the full announcement to learn more: https://hubs.la/Q04zMCdj0

LUX Infusion Expands Access to Hemophilia Care with Qfitlia (fitusiran)

10/07/2026

𝗣𝗶𝗰𝘁𝘂𝗿𝗲 𝗬𝗼𝘂𝗿𝘀𝗲𝗹𝗳 𝗶𝗻 𝗢𝘂𝗿 𝟮𝟬𝟮𝟳 𝗖𝗮𝗹𝗲𝗻𝗱𝗮𝗿!

What’s a moment you’d love to share? A milestone, a memorable trip, time with loved ones—or simply doing something you enjoy?

LUX Infusion is accepting photos for our 2027 “Living a Spectacular Life” calendar! Help us celebrate the everyday joys and meaningful moments of life in our bleeding disorders community.

Only first names will be included with selected photos.

𝗬𝗼𝘂𝗿 𝗳𝗮𝘃𝗼𝗿𝗶𝘁𝗲 𝗺𝗲𝗺𝗼𝗿𝘆 𝗰𝗼𝘂𝗹𝗱 𝗶𝗻𝘀𝗽𝗶𝗿𝗲 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝗮𝗹𝗹 𝘆𝗲𝗮𝗿 𝗹𝗼𝗻𝗴. 𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗽𝗵𝗼𝘁𝗼 𝗯𝘆 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟭 𝘂𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗯𝗲𝗹𝗼𝘄!
https://hubs.la/Q04zymSc0

10/06/2026

𝗪𝗵𝘆 𝘄𝗮𝘀 𝗵𝗲𝗺𝗼𝗽𝗵𝗶𝗹𝗶𝗮 𝗼𝗻𝗰𝗲 𝗸𝗻𝗼𝘄𝗻 𝗮𝘀 “𝘁𝗵𝗲 𝗿𝗼𝘆𝗮𝗹 𝗱𝗶𝘀𝗲𝗮𝘀𝗲”? 👑

Hemophilia has a fascinating history, including a genetic connection that spread through several of Europe’s royal families and helped shape our early understanding of the condition.

Today, we know far more about hemophilia—how it’s inherited and how it can be managed. Take a look back at the history behind one of the world’s most well-known bleeding disorders and how care has evolved.

Read more: https://hubs.la/Q04z7Nfc0

The Royal Disease: How Hemophilia Shaped Europe’s Royal Families

10/02/2026

𝗡𝗲𝘄 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗼𝗳𝗳𝗲𝗿𝘀 𝗲𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗴𝗵𝘁 𝗳𝗼𝗿 𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻 𝘄𝗶𝘁𝗵 𝘀𝗲𝘃𝗲𝗿𝗲 𝗵𝗲𝗺𝗼𝗽𝗵𝗶𝗹𝗶𝗮 𝗔 𝘄𝗵𝗼 𝗵𝗮𝘃𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗲𝗱 𝗳𝗮𝗰𝘁𝗼𝗿 𝗩𝗜𝗜𝗜 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀.

In a small, single-center study, children who received Hemlibra® (emicizumab-kxwh) alongside low-dose immune tolerance induction achieved tolerance faster and experienced significantly fewer treated bleeds than a historical comparison group receiving immune tolerance induction alone.

Complete immune tolerance was achieved in 78% of children receiving the combination, compared with 36% in the comparison group. The median time to tolerance was also shorter: nine months versus 19 months.

While larger prospective studies are needed, these findings may help inform more effective and manageable approaches to eliminating inhibitors while protecting children from bleeds during treatment.

Read the study: https://hubs.la/Q04z3rpb0

09/25/2026

For people living with bleeding disorders, having the right medication support can make a meaningful difference in managing care with confidence.

This 𝗪𝗼𝗿𝗹𝗱 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗶𝘀𝘁𝘀 𝗗𝗮𝘆, we’re recognizing the pharmacists who help support the bleeding disorders community through medication expertise, careful coordination, patient education, and collaboration with providers and care teams.

At LUX Infusion, we’re grateful for the pharmacists who help patients and families navigate complex therapies while keeping individualized care at the center of every decision.

Thank you for the expertise, dedication, and compassion you bring to the bleeding disorders community every day. 💙

09/17/2026

𝗖𝗼𝘂𝗹𝗱 𝗮 𝗛𝗲𝗺𝗼𝗽𝗵𝗶𝗹𝗶𝗮 𝗔 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗛𝗮𝘃𝗲 𝗮 𝗙𝘂𝘁𝘂𝗿𝗲 𝗶𝗻 𝗧𝘆𝗽𝗲 𝟯 𝗩𝗪𝗗? 🩸

Researchers are studying whether emicizumab, currently used to prevent bleeding in people with hemophilia A, could also help prevent bleeds in people with Type 3 von Willebrand disease (VWD).

The Phase III WILL-EMI study is evaluating the efficacy and safety of emicizumab prophylaxis in Type 3 VWD, the rarest and most severe form of the condition.

The study is ongoing, but it raises an important question: Could therapies developed for one bleeding disorder help advance care for another?

Learn more: https://hubs.la/Q04wJ2_v0

09/11/2026

𝗣𝗮𝗶𝗻 𝗰𝗮𝗻 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝗹𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗮 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿, 𝗯𝘂𝘁 𝗶𝘁 𝘀𝗵𝗼𝘂𝗹𝗱𝗻’𝘁 𝗯𝗲 𝗶𝗴𝗻𝗼𝗿𝗲𝗱.

For people with hemophilia and other bleeding disorders, pain may be associated with an acute bleed or develop over time from repeated bleeding into joints and muscles.

This September during Pain Awareness Month, it’s an important reminder to talk with your care team about new, changing, or ongoing pain. Understanding what’s causing it can help guide treatment, protect joint health, and support your quality of life.

Pain is information. Make it part of the conversation with your bleeding disorders care team.

09/08/2026

𝗔 𝗻𝗲𝘄 𝘀𝗲𝗮𝘀𝗼𝗻 𝗶𝘀 𝗮 𝗴𝗼𝗼𝗱 𝘁𝗶𝗺𝗲 𝘁𝗼 𝗰𝗵𝗲𝗰𝗸 𝗶𝗻 𝘄𝗶𝘁𝗵 𝘆𝗼𝘂𝗿 𝘄𝗲𝗹𝗹𝗻𝗲𝘀𝘀.

As summer winds down and fall routines begin, it’s a good opportunity for people living with bleeding disorders to think beyond treatment alone.

Staying active in ways that work for your body, prioritizing joint health, keeping up with routine care, and staying connected to your healthcare team can all be part of living well with a bleeding disorder.

At LUX Infusion, we believe wellness is about supporting the whole person—not just their therapy. As the seasons change, we’re here to help patients stay prepared, supported, and confident in their care.

09/01/2026

𝗟𝗨𝗫 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗮𝘁 𝗙𝗮𝗺𝗶𝗹𝗶𝗮 𝗱𝗲 𝗦𝗮𝗻𝗴𝗿𝗲 𝟮𝟬𝟮𝟲

We’re heading to Anaheim! LUX Infusion will be at Familia de Sangre (FDS), September 4–6, connecting with the bleeding disorders community and the people working every day to improve access, support, and care.

Stop by 𝗯𝗼𝗼𝘁𝗵 𝟭𝟭𝟵 to meet John Martinez, Gabriela Griffin, and Hector Heer and learn more about how LUX supports patients and families living with bleeding disorders.
We’d love to see you there!